AI assistant
Comvita Limited — Director's Dealing 2019
Jun 21, 2019
66182_rns_2019-06-21_18492f36-50f2-4111-a3b0-ea7e85778ad5.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [91 x 25] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and Name of listed issuer: Date this disclosure made: Date of last disclosure:
==> picture [218 x 84] intentionally omitted <==
Comvita Limited 21-Jun-19 22-May-19
Director or senior manager giving disclosure
Full name(s): Name of listed issuer: Name of related body corporate (if applicable): Position held in listed issuer:
Neil John Craig Comvita Limited n/a Company Chair
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products: Nature of the affected relevant interest(s): For that relevant interest- Number held in class before acquisition or disposal: Number held in class after acquisition or disposal: Current registered holder(s): Registered holder(s) once transfers are registered:
Ordinary Shares Beneficial owner of the shares 9,960 Neil John Craig - Start Scheme A/C; 500,000 Neil John Craig - Custodial Services Ltd; 11,098 Neil John Craig - Start Scheme A/C; 75,000 Sheryl Denise Tebbutt (Partner) - Custodial Services Ltd; 25,000 Anna Beth Craig (Daughter) - Custodial Services Ltd; 420,000 Neil John Craig, Sheryl Denise Tebbutt, Sharp Tudhope Trustee Services No 27 Ltd for Eaglesham Trust - Custodial Services Ltd Neil John Craig - Start Scheme A/c Neil John Craig - Start Scheme A/c
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: Details of transactions requiring disclosure- Date of transaction: Nature of transaction: Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration: Number of financial products to which the transaction related:
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) — include the following details Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any):
1 20-Jun-19 1,138 ordinary shares acquired pursuant to a non-discretionary fixed trading plan, to which shares will be acquired on a monthly basis without interruption over the next 12 months. This is the second acquisition of shares pursuant to the fixed trading plan. N/A $3,936 1
No N/A N/A
Certification
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature:
21-Jun-19
==> picture [49 x 45] intentionally omitted <==
==> picture [91 x 25] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | Comvita Limited | |
| Date this disclosure made: | 21-Jun-19 | |
| Date of last disclosure: | 22-May-19 |
| Director or senior manager giving disclosure | ||
|---|---|---|
| Full name(s): | Christine MaryFleury | |
| Name of listed issuer: | Comvita Limited | |
| Name of related body corporate (if applicable): | n/a | |
| Position held in listed issuer: | Board Secretary |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives) | Summary of acquisition or disposal of relevant interest (excluding specified derivatives) | ||
|---|---|---|---|
| Class of affected quoted financial products: | Ordinary Shares | ||
| Nature of the affected relevant interest(s): | Craigs Start Scheme A/C - registered holder | ||
| For that relevant interest- | |||
| Number held in class before acquisition or disposal: | Craigs Start Scheme A/C - 4,493 | ||
| Tutamai Trust - 110,000 | |||
| Number held in class after acquisition or disposal: | Craigs Start Scheme A/C - 5,545 | ||
| Tutamai Trust-110,000 | |||
| Current registered holder(s): | Christine MaryFleury | ||
| Registered holder(s)once transfers are registered: | Christine MaryFleury | ||
| Details of transactions giving rise to acquisition or disposal | |||
| Total number of transactions to which notice relates: | 2 | ||
| Details of transactions requiring disclosure- | |||
| Date of transaction: | Various | ||
| Nature of transaction: | 573 ordinary shares acquired pursuant to a non- | ||
| discretionary fixed trading plan, to which shares | |||
| will be acquired on a monthly basis without | |||
| interruption over the next 12 months. This is | |||
| the first acquisition of shares pursuant to the | |||
| fixed trading plan. | |||
| 479 ordinary shares acquired through Craigs | |||
| Start SchemeA/c. | |||
| Name of any other party or parties to the transaction (if known): | n/a | ||
| The consideration, expressed in New Zealand dollars, paid or received for the acquisition | $3,973 | ||
| or disposal. If the consideration was not in cash and cannot be readily by converted into a | |||
| cash value,describe the consideration: | |||
| Number of financial products to which the transaction related: | 1 | ||
| If the issuer has a financial products trading policy that prohibits directors or senior | |||
| managers from trading during any period without written clearance (a closed period) | |||
| include the following details— | |||
| Whether relevant interests were acquired or disposed of during a closed period: | No | ||
| Whether prior written clearance was provided to allow the acquisition or disposal to | n/a | ||
| proceed duringthe closedperiod: | |||
| Date of the prior written clearance (if any): | n/a | ||
| Certification | |||
| I certify that, to the best of my knowledge and belief, the information contained in this | |||
| disclosure is correct and that I am duly authorised to make this disclosure by all persons for | |||
| whom it is made. | |||
| Signature of director or officer: | |||
| Date of signature: | 21-Jun-19 |